As Medicare starts covering GLP-1s for weight loss, state Medicaid programs pull back. How do economics, stigma and bias influence who “deserves” treatment for obesity and who gets shut out? @chjreportinghealth.bsky.social centerforhealthjournalism.org/our-work/ins...
The Health Divide: This breakthrough obesity drug is creating a big new health disparity
What happens when an expensive drug that works well for a condition affecting millions of people remains out of reach to many of those who would benefit?
centerforhealthjournalism.org